Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Alpha Tau Medical Ltd is an Israel-based medical technology company engaged in the research, development, and commercialization of innovative cancer treatment technologies. The Company focuses on Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy), a platform designed for the treatment of solid tumors through the localized delivery of alpha radiation within tumor tissue. Its technology utilizes radioactive radium-224 sources that release short-range alpha particles intended to damage and destroy cancer cells while limiting exposure to surrounding healthy tissue. The Company conducts activities related to product development, clinical studies, regulatory approval processes, and commercialization. Alpha Tau Medical Ltd serves the oncology sector and carries out its operations directly and through its subsidiary, Healthcare Capital Corp.
Find out what a historical investment in ALPHA TAU MEDICAL LTD-CL A would be worth today using our DRTS stock calculator.
Market Capitalisation
$1.32B
Price-earnings ratio
-
Dividend yield
0.00%
Volume
498.33K
High today
$14.40
Low today
$13.41
Open price
$14.38
52-week high
$14.30
52-week low
$3.00
Ready to start your investing journey with Stake?
Open an accountThis is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.

Invest in DRTS on Stake
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
DRTS related stocks